Islamic Republic of Afghanistan Ministry of Public Health

National Medicine and Healthcare Products Regulatory Authority

National Inspection Checklist for

Retail Pharmacies

February 2017

ii

This document is made possible by the generous support of the American people through the US Agency for International Development (USAID), under the terms of leader with associate cooperative agreement number 306-A-00-11-00532-00 under leader award number GHN-A-00-07-00002-00. The contents are the responsibility of the National Medicine and Healthcare Products Regulatory Authority-Ministry of Public Health of the Islamic Republic of Afghanistan and do not necessarily reflect the views of USAID or the United States Government. About SPS

The Strengthening Pharmaceutical Systems (SPS) Associate Award Program strives to build capacity within developing countries to effectively manage all aspects of pharmaceutical systems and services. SPS focuses on improving governance in the pharmaceutical sector, strengthening pharmaceutical management systems and financing mechanisms, containing antimicrobial resistance, and enhancing access to and appropriate use of medicines.

Strengthening Pharmaceutical Systems Pharmaceutical & Health Technologies Group

Management Sciences for Health 4301 North Fairfax Drive, Suite 400

Arlington, VA 22203 USA Telephone: 703.524.6575

Fax: 703.524.7898 E-mail: sps@msh.org

Web: www.msh.org/sps

iii

CONTENTS Abbreviations and Acronyms .................................................................................................. iv Foreword ....................................................................................................................................v Laws, Regulations, Policies, and Guidelines Applied in this Checklist ....................................1 Section 1. General Information ..................................................................................................2 Section 2. Registration Certificate .............................................................................................3 Section 3. Legality of the Stocked Medicinal Products .............................................................4 Section 4. Product Label Examination.......................................................................................5 Section 5. Management of Narcotics and Controlled Medicines ..............................................6 Section 6. Storage Conditions (Storage of Pharmaceutical Products) .......................................7 Section 7. General Condition of the Premises ...........................................................................8 Section 8. Staff and Services .....................................................................................................9 Section 9. Reference Materials ................................................................................................10 Section 10. Scoring ..................................................................................................................11 Section 11. Any Other Observations and Remarks .................................................................12 Section 12. Recommendations and Actions .............................................................................13 Section 13. Owner’s/Technical In-Charge’s Declaration ........................................................14 Section 14. Time Completed....................................................................................................15 Section 15. Names and Signatures of Inspectors .....................................................................16 Annex 1. Suspect Medicine Sample Collection for Quality Test ............................................17 Annex 2. Quarantine and Confiscation Form ..........................................................................18 Annex 3. Category 2 Medicines in the LML Controlled Medicine List ..................................19 Annex 4. Narcotic and Controlled Substances ........................................................................20

iv

ABBREVIATIONS AND ACRONYMS LML licensed medicine list MIMMAR Manufacturing and Importing Medicines and Medical Appliance

Regulation, official gazette issue number 916, February, 24, 2007 ML Medicine Law, official gazette issue number 963, November, 18, 2008 MOPH Ministry of Public Health MRG Medicine Registration Guidelines, 2014 MSH Management Sciences for Health NMHRA National Medicine and Healthcare Products Regulatory Authority NMP National Medicines Policy, 2014 NPNCM National Policy for Narcotic and Controlled Medicines, 2016 NPQAP National Pharmaceutical Quality Assurance Policy, 2105 NPWMSDPP National Policy for Waste Management & Safe Disposal of Pharmaceutical

Products, 2016 PR Pharmacy Regulation, official gazette issue number 916,February, 24, 2007 SPS Strengthening Pharmaceutical Services TIC technical in-charge USAID US Agency for International Development

v

FOREWORD The National Medicine and Healthcare Products Regulatory Authority (NMHRA) was established under the Ministry of Public Health (MOPH) in 2016, with the mission of accessing quality, safe, and efficacious medicines and health products through regulation and control of production, importation, exportation, distribution, and use. The objective of the organization is the development and enforcement of effective standards to optimize the safety, efficacy, quality, and affordability of medicines and health products throughout the country. I have the pleasure of introducing the first-ever National Inspection Checklist for Retail Pharmacies for the inspection of retail pharmacies. To ensure that the inspection of retail pharmacies is carried out with good standard, MOPH initiated the development of the retail pharmacies inspection checklist to guide the inspectors. The objective of using the checklist for inspection is to enforce the implementation of the relevant law and regulations by the retail pharmacies for assuring the quality and safety of their practices and the pharmaceuticals during procurement, storage, and distribution of medicines, and for delivering high-quality services to the population. To ensure technical quality and appropriateness to the local context, the national inspection checklist was developed by an MOPH-delegated technical committee with the financial and technical support of the Strengthening Pharmaceutical Systems (SPS) project. MOPH is committed to overseeing the implementation of the checklist at all retail pharmacies across the country. The NMHRA in the MOPH wishes to acknowledge the contributions of the members of the task force for the development of the national inspection checklist for retail pharmacies. Acknowledgement is given to the following people from NMHRA-MOPH, in particular:

• Pharmacist Mohammad Zafar Barry • Pharmacist Sayed Asadullah Akhlaqizada • Pharmacist Sayed Nazir Hussain Hashemi • Pharmacist Mir Padshah Zohori • Pharmacist Muhammad Naeem Yaqoby • Pharmacist Mohammad Ibrahim Arab • Pharmacist Mohammad Hanif Nabavi • Pharmacist Zekria Fatehzada • Pharmacist Mohammad Asef Yari • Pharmacist Mohammad Osman Zaki

The NMHRA would also like to thank the following technical advisors of the SPS project, who provided technical support to the development and formulation of the checklist:

• Pharmacist Mohammad Basir, Pharmaceutical Regulatory System Program Manager • Pharmacist Sohail Nazari, Pharmaceutical Regulatory System Technical Officer • Pharmacist Mohammad Zafar Omari, Chief of Party • Pharmacist Shiou-Chu Judy Wang, Senior Technical Adviser, SPS in USA • Dr. Paul Ickx, Senior Principal Technical Advisor, SPS in France

vi

I wish to commend the SPS project funded by the US Agency for International Development (USAID) and implemented by Management Sciences for Health (MSH) for their tremendous technical support. I also thank the National Inspection Checklists Development Task Force members and all those who contributed to the development of this checklist.

1

LAWS, REGULATIONS, POLICIES, AND GUIDELINES APPLIED IN THIS CHECKLIST

This inspection checklist was developed according to the most recent effective laws and regulations governing pharmaceutical practices and services. The laws and regulations applied in this checklist are listed below with their acronyms.

• MIMMAR: Manufacturing and Importing Medicines and Medical Appliance Regulation, official gazette issue number 916, February, 24, 2007

• ML: Medicine Law, official gazette issue number 963, November, 18, 2008

• MRG: Medicine Registration Guidelines, 2014

• NMP: Afghanistan National Medicines Policy, 2014

• NPNCM: National Policy for Narcotic and Controlled Medicines, 2016

• NPQAP: National Pharmaceutical Quality Assurance Policy, 2105

• NPWMSDPP: National Policy for Waste Management and Safe Disposal of

Pharmaceutical Products, 2016

• PR: Pharmacy Regulation, official gazette issue number 916, February, 24, 2007

2

SECTION 1. GENERAL INFORMATION Date of Inspection (Persian/Shamsi calendar)

/ / / (day/month/year)

Date of Last Inspection (Persian/Shamsi calendar)

/ / / (day/month/year)

Time Started _____: _____ am/pm (hour and minutes) Type of Inspection (circle one) Routine/

Comprehensive Concise

Follow-up

Special

Name of the Pharmacy Pharmacy Inauguration Number Date of Establishment Type of Pharmacy Registered (circle one) First class Second

class Third class

Other

Location Province: _______________ District: ________________ Village/town: _______________ Street: _____________________ GPS (latitude) if GPS device available: _______________ GPS (longitude) if GPS device available: _______________

Physical Address Telephone Number E-mail Address Name of the Proprietor Name of Technical In-Charge Technical In-Charge’s Certificate of Practice Number

3

SECTION 2. REGISTRATION CERTIFICATE Inspect the registration certificates of the pharmacy and the TIC according to the requirements in the indicated laws or regulations. If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirement 1 or 0 Remarks

2.1 Is the pharmacy registration/inauguration certificate/ letter available in the pharmacy? (20 PR 2007)

2.2 Is the pharmacy registration/inauguration certificate/ letter displayed in a prominent location? (20 PR 2007)

2.3 Is the valid certificate of practice of the TIC available? (20 PR 2007)

2.4 Is the valid certificate of practice of the TIC displayed in a prominent location? (20 PR 2007)

2.5 Does the TIC’s education qualification comply with the registered classification of the pharmacy? (9 PR 2007) If the certificate is not available for inspection, indicate N/A in the 1 or 0 column.

Score for Registration Certificate Index Add up the outlet’s score for questions 2.1 to 2.5 and record the score in the space provided in the next column. The range for this index is 0–5. (If question 2.5 is not observed, the range for this index is 0–4.)

Score: Score: ( / × 100) = %

4

SECTION 3. LEGALITY OF THE STOCKED MEDICINAL PRODUCTS Walk through the pharmacy and do a general scan of the medicines or products stored or displayed in the pharmacy according to the requirements in the indicated laws or regulations. If any suspect medicines are found, collect the samples for quality control (QC) testing and fill the sampling form (annex 1). If any nonconformity is found, confiscate or quarantine the medicines or products and fill in the Confiscation/Quarantine Form (annex 2). Randomly select at least 5 items for inspection. If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirements 1 or 0 Remarks

3.1 Are all the inspected medicines in accordance with the national LML? (9 ML 2008)

3.2 Are there no narcotic substances (annex 4) and alcoholic beverages found for sale in the pharmacy? (44 ML 2008)

3.3 Are there no counterfeit and substandard medicines found for sale in the pharmacy? (44 ML 2008)

3.4 Are there no nonmedical items found for sale in the pharmacy? (2 and 18 PR 2007)

3.5 Are there copies of receipts/invoices for the procurement of medicines and medical equipment from importers/ wholesalers? (21 PR 2007 and 15 NPQAP 2015)

3.6 Are the inspected medicine purchased from registered importers and wholesalers? (21 PR 2007 and 15 NPQAP 2015)

Score for Legality of Stocked Products Index Add up the outlet’s score for questions 3.1−3.6 and record the score in the space provided in the next column. The range for this index is 0–6.

Score: Score: ( / × 100) = %

5

SECTION 4. PRODUCT LABEL EXAMINATION Closely examine the product labels according to the requirements in the indicated laws or regulations. Randomly select at least 5 items for inspection. If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirements 1 or 0 Remarks

4.1 Are all the labels of the inspected medicines printed in at least one of the national languages or English? (2 MRG 2014)

4.2 Are all the labels of the inspected medicines in accordance with the labeling requirements specified in the regulation and/or guidelines? (24 MIMMAR 2007 and 2 MRG 2014)

4.3 Is the information for all the inspected medicines’ leaflets in accordance with the requirements specified in the regulation and/or guidelines? (25 MIMMAR 2007 and 2 MRG 2014)

4.4 Do all the inspected medicines have valid expiry dates? (7 NPQAP 2015)

Score for Product Label Examination Index Add up the outlet’s score for questions 4.1−4.4 and record the score in the space provided in the next column. The range for this index is 0–4.

Score: Score: ( / × 100) = %

6

SECTION 5. MANAGEMENT OF NARCOTICS AND CONTROLLED MEDICINES Inspect the controlled medicines, including physical examinations and storage, as well as documentation of controlled medicines. If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirements 1 or 0 Remarks

5.1 Is there at least one lockable cabinet for storage of all controlled medicines (category 2) in the pharmacy? (5 and 12 NPNCM 2016)

5.2 Is the entire inventory of category 2 controlled medicines kept in the lockable cabinet? (5 and 12 NPNCM 2016)

5.3 Are all the inspected controlled medicines within their labeled expiry dates? Randomly inspect 3 items. (7 NPQAP 2015)

5.4 Does the pharmacy have a controlled medicine registration book? (15 and 35 PR 2007)

5.5 (Inspect the most recent prescriptions.) Are controlled medicines and narcotic prescriptions entered correctly into the registration book? (15 PR 2007) (If the answer to 5.4 is no, answer N/A to this question.)

5.6 Are the prescriptions for narcotic medicines (category 2) kept secure to prevent access by unauthorized persons? (15 PR 2007)

Score for Management of Controlled Medicines Add up the outlet’s score for questions 5.1−5.6 and record the score in the space provided in the next column. The range for this index is 0−6. (If question 5.5 is not observed, the range for this index is 0–5.)

Score: Score: ( / × 100) = %

7

SECTION 6. STORAGE CONDITIONS (STORAGE OF PHARMACEUTICAL PRODUCTS)

Inspect the storage conditions at the pharmacy as per the following requirements. If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirements 1 or 0 Remarks

6.1 Is the temperature in the pharmacy compatible with drug storage requirements? (15−25 °C or depending on climatic conditions up to 30 °C) (17 PR 2007 and 50 ML 2008)

6.2 Is there a temperature monitoring device available for recording the temperature within the pharmacy? (17 PR 2007 and 50 ML 2008) • If yes, how often is the temperature recorded? (select

one)

Frequency: _____________ Irregularly No records

6.3 Does the pharmacy have a functional refrigerator(s) for storing temperature-sensitive items? (17 PR 2007 and 50 ML 2008)

6.4 Are any temperature-sensitive medicines found stored or displayed outside the refrigerator(s)? (17 PR 2007 and 50 ML 2008)

6.5 Are all the inspected medicines in the refrigerator in within their labeled expiry dates? Randomly select 3 items. (7 NPQAP 2015)

6.6 Is there a temperature monitoring device available for recording the temperature in the refrigerator? (17 PR 2007 and 50 ML 2008) • If yes, how often is the temperature recorded?

(select one)

Frequency: _________________ Irregularly No records

6.7 Is there a dedicated area for placement of expired, returned, recalled, and quarantined medicines and if so, is it clearly labeled? (9 NPWMSDPP 2015 and 7 NPQAP 2015)

Score for Storage Conditions Index Add up the outlet’s score for questions 6.1−6.7 and record the score in the space provided in the next column. The range for this index is 0–7.

Score: Score: ( / × 100) = %

8

SECTION 7. GENERAL CONDITION OF THE PREMISES Is the general condition of the premises of the pharmacy considered appropriate in accordance with the following requirements? If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirements 1 or 0 Remarks

7.1 Does the retail pharmacy operate at the address as registered for the business? (7 PR 2007)

7.2 Is the space compliant with the registered classification of a retail pharmacy? (19 ML 2008)

• First-class pharmacy: 53 square meters • Second-class pharmacy: 43 square meters • Third-class pharmacy: 38 square meters • Others: 24 square meters

7.3 Is the pharmacy not used as a physician’s clinic? (9 PR 2007)

7.4 Are the walls, floors, and celling are in good condition without signs of humidity, mold, and cracking? (17 PR 2007 and 50 ML 2008)

7.5 Is the entire pharmacy area clean? (18 PR 2007)

7.6 Is there a ventilation system and is it functional? (17 PR 2007)

Score for General Condition of the Premises Index Add up the outlet’s score for questions 7.1−7.6 and record the score in the space provided in the next column. The range for this index is 0−6.

Score: Score: ( / × 100) = %

9

SECTION 8. STAFF AND SERVICES Are the staff and services of the pharmacy considered appropriate in accordance with the following requirements? If the requirements are met, please indicate 1 for yes or passed in the 1 or 0 column; if the requirements are not met, indicate 0 for no or failed.

Requirements 1 or 0 Remarks

8.1 Is the TIC present at the pharmacy on the day of the inspection? (3 PR 2007)

8.2 Does the TIC wear a clean white uniform? (26 PR 2007)

8.3 Does the TIC give clear and understandable instructions and necessary information to patients/customers regarding the prescribed or dispensed medicines? (26 PR 2007) If the observation did not occur, score N/A.

8.4 Does the prescription of dispensed medicine have the price written on the top and has it been stamped? (26 PR 2007) If the observation did not occur, score N/A.

8.5 Is the percentage of profit in accordance with the provisions of the law? (The profit in sales of medicine and medicinal products cannot be more than 15% of the purchase price.) (17 ML 2008) If the observation did not occur, score NA.

8.6 Is there a registration book for medicines other than narcotics and controlled medicines to enter prescriptions? (15 and 35 PR 2007)

8.7 Does the retail pharmacy have a stamp? (35 PR 2007) 8.8 Does the retail pharmacy have a standard signboard? (35

PR 2007)

Score for Staff and Services Index Add up the outlet’s score for questions 8.1−8.8 and record the score in the space provided in the next column. The range for this index is 0−8. (If questions 8.3, 8.4, and 8.5 are not observed, the range for this index is 0−5.)

Score: Score: ( / × 100) = %

10

SECTION 9. REFERENCE MATERIALS Please ask the pharmacy staff to present the following reference materials. This section is not scored.

Requirements Yes No Remarks

9.1 Valid/effective Afghan Medicines Law (Official Gazette Number 963, 2008)

9.2 Valid/effective Pharmacy Regulation (Official Gazette Number 916, 2007)

9.3 Valid National Licensed Medicines List, 2014 9.4 Valid National Essential Medicines List, 2014 9.5 A copy of updated Afghan National Formulary, 2015 9.6 Updated National Standard Treatment Guidelines, 2013 9.7 Updated National Medicines Policy, 2014 9.8 Updated National Pharmaceutical Quality Assurance Policy,

2015

9.9 Updated National Policy for Narcotic and Controlled Medicines, 2016

9.10 Updated National Policy for Waste Management and Safe Disposal of Pharmaceutical Products, 2016

11

SECTION 10. SCORING Please fill in the scores for sections 2−8 into the following table and determine the overall compliance score in the Result column.

Date Sectional scores obtained (%) Total score (A)

Total points

(B)

Result (%)

(A/B*100) 2 3 4 5 6 7 8

This inspection (fill in date)

Last inspection (fill in date)

% point change Note: Please make two copies (use carbon paper or make a photocopy if possible) for sections 11−15. The inspectors keep the original copy and give the duplicate copy to the pharmacy. Advise the proprietor and the TIC to file it in a designated folder for records and actions and for future inspections.

12

SECTION 11. ANY OTHER OBSERVATIONS AND REMARKS Provide information about any observations in addition to the information obtained in the checklist, if available. Use a separate sheet if the space provided is not enough.

13

SECTION 12. RECOMMENDATIONS AND ACTIONS

From the inspection results, identify the most critical issues for correction or improvements, such as registration, qualification of TIC, legality or quality of products, accountability of controlled medicines, etc. If regulatory measures or penalties should be applied, specify it in the “Actions agreed to take and timeline” column. Use carbon paper or a photocopier to duplicate this section and give one copy to the pharmacy for taking actions and follow-up.

Name of the pharmacy: _________________________________ Date:_____________ Address:

No. Issues that require attention and correction

Actions agreed to take and timeline

1 2 3 4 5 6 7

14

SECTION 13. OWNER’S/TECHNICAL IN-CHARGE’S DECLARATION I ( ) the owner and ( ) the TIC of the said pharmacy certify that the information and observations recorded on this form during the inspection of the pharmacy were true and correct and that the identified issues and corrective actions were communicated and agreed. Proprietor of pharmacy Technical in-charge Name: Name: Signature: Signature: Date: Date:

15

SECTION 14. TIME COMPLETED Document the time when the inspection is finished, including completing the checklist, collecting samples for QC testing and confiscation, scoring for this inspection, and communicating with the proprietor and the TIC. Time completed: Hour : minute am / pm

16

SECTION 15. NAMES AND SIGNATURES OF INSPECTORS Name(s) of inspector(s) Designation(s) Signature(s) Date

Acknowledge the proprietor, the TIC, and other pharmacy staff for their assistance during the inspection.

17

ANNEX 1. SUSPECT MEDICINE SAMPLE COLLECTION FOR QUALITY TEST

The sample collection form should be filled in duplicate. The inspectors keep the original copy and give the pharmacy the duplicated copy. The pharmacy should file it in a designated folder for records. If quarantine is required, fill the “Total quantity quarantined” column.

Ministry of Public Health National Medicine and Healthcare Products Regulatory Authority

Post-Market Services Integration Directorate Inspection and Enforcement of Law and Regulation Department

Suspect Medicine Sample Collection for Quality Test

Name of the pharmacy

Date Address

Name of proprietor

Signature Name of technical in-charge Signature

S/no Generic name Brand name Batch no Mfg date Exp date Quantity Manufacturer Importer Total quantity quarantined

1

2

3

4

5

6 Samples collected by (inspector): ________________________ Signature: ______________

Samples collected by (inspector): ________________________ Signature: _______________

18

ANNEX 2. QUARANTINE AND CONFISCATION FORM

Fill 2 copies of the quarantine and confiscation form. The inspectors keep the original copy and give the pharmacy the duplicate copy. The pharmacy should file it in a designated folder for records.

Ministry of Public Health National Medicine and Healthcare Products Regulatory Authority

Post-Market Services Integration Directorate Inspection and Enforcement of Law and Regulation Department

Quarantine and Confiscation Form

Name of the pharmacy

Date Address

Name of proprietor

Signature Name of the technical in-charge Signature

Please select the appropriate reason for sampling. 1. Quarantine 2. Confiscation S/no Generic name Brand name Batch no Mfg date Exp date Manufacturer Importer Total quantity

quarantined 1

2

3

4

5

6 Confiscated or quarantined by (inspector): ________________________ Signature: ______________

Confiscated or quarantined by (inspector): ________________________ Signature: ______________

19

ANNEX 3. CATEGORY 2 MEDICINES IN THE LML CONTROLLED MEDICINE LIST

Category 2

substances Controlled medicines in LML 2014 that are derived from category 2 substances

1 Fentanyl Fentanyl 0.05 mg/ml, in 2 ml ampoule injection solution

2 Methadone

• Methadone 10 mg/ml in 1-ml ampoule injection • Methadone 10 mg/ml, oral solution • Methadone 10 mg tablet • Methadone 5 mg/ml, oral solution • Methadone 5 mg tablet

3 Morphine • Morphine hydrochloride 10 mg/ml in 1-ml ampoule

injection • Morphine sulfate 10 mg/ml in 1-ml ampoule injection

4 Opium Opium tincture 10% oral solution

5 Pethidine medium A, B, C

• Pethidine 100 mg tablet • Pethidine 50 mg tablet • Pethidine 50 mg/ml, injection ampoule

20

ANNEX 4. NARCOTIC AND CONTROLLED SUBSTANCES

Category 1–Plants and Narcotic Substances: Prohibited Drug of Abuse with No Medical Use S/no Name S/no Name

1 (+)-Lysergide 37 Dimethylthiambutene 2 2C-B (2,5-dimethoxy-4-

bromophenethylamine) 38 Dioxaphetyl butyrate

3 3-Methylfentanyl 39 Dipipanone 4 3-Methylthiofentanyl 40 DMA (dimethoxyamphetamine) 5 4-MTA (4-methylthioamphet-

amine 41 DMHP (dimethylheptylpyran)

6 Acetorphine 42 DMT (N,N-dimethyltryptamine) 7 Acetyl-alpha-methylfentanyl 43 DOET (2,5-dimethoxy-4-ethylamphetamine) 8 Acetyldihydrocodeine 44 Drotebanol 9 Acetylmethadol 45 Ethylmethylthiambutene

10 Allylprodine 46 Eticyclidine 11 Alphameprodine 47 Etilamfetamine 12 Alphamethadol 48 Etonitazene 13 Alpha-methylfentanyl 49 Etorphine 14 Alpha-methyl-thiofentanyl 50 Etoxeridine 15 Aminorex 51 Etryptamine 16 Benzethidine 52 Fenetylline 17 Benzylmorphine 53 Furethidine 18 Betacetylmethadol 54 Heroin 19 Beta-hydroxyfentanyl 55 Hydromorphinol 20 Beta-hydroxy-3-methylfentanyl 56 Hydroxypethidine 21 Betameprodine 57 Ketobemidone 22 Betamethadol 58 Levomoramide 23 Betaprodine 59 Levophenacylmorphane 24 Brolamfetamine 60 MDE, N-ethyl MDA (3,4-methylenedioxy-N-

ethylamphetamine) 25 Cannabis and cannabis resin 61 MDMA (3,4-Methylenedioxymethamphetamine) 26 Cathinone 62 Mecloqualone 27 Clonitazene 63 Mescaline 28 Concentrate of poppy straw 64 Methaqualone 29 Desomorphine 65 Methcathinone 30 DET (N,N-diethyltryptamine) 66 Methyl-4-aminorex 31 Dextromoramide 67 Methyldesorphine 32 Diampromide 68 Methyldihydromorphine 33 Diethylthiambutene 69 MMDA (3-methoxy-4,5-methylenedioxyamphet-

amine) 34 Difenoxine 70 Morpheridine 35 Dimenoxadol 71 Morphine methobromide and other pentavalent

nitrogen morphine derivatives 36 Dimepheptanol 72 MPPP (Desmethylprodine, 1-methyl-4-phenyl-4-

propionoxypiperidine)

21

S/no Name S/no Name 73 Myrophine 101 STP, DOM (2,5-dimethoxy-4-methylamphetamine) 74 N-hydroxy MDA (3,4-meth-

ylenedioxy-N-hydroxyamphet-amine)

102 Tenamfetamine

75 Nicocodine 103 Tenocyclidine 76 Nicomorphine 104 Thebacone 77 Noracymethadol 105 Thiofentanyl 78 Norlevorphanol 106 Tilidine 79 Normethadone 107 TMA (trimethoxyamphetamines) 80 Normorphine 108 Trimeperidine 81 Norpipanone 109 Tetrahydrocannabinol, the following isomers, and

their stereochemical variants: • Tetrahydro-7,8,9,10 trimethyl-6,6,9 pentyl-3 6H-

dibenzo[b,d] pyranne o1-1 • (9R, 10aR)-Tetrahydro-8,9,10,10a trimethyl-6,6,9

pentyl-3 6H-dibenzo[b,d]pyranne o1-1 • (6aR,9R, 10aR)-Tetrahydro-6a,9,10,10a trimethyl-

6,6,9 pentyl-3 6H-dibenzo[b,d] pyranne o1-1 • (6aR,10aR)-Tetrahydro-6a,7,10,10a trimethyl-

6,6,9 pentyl-3 6H-dibenzo[b,d] pyranne o1-1 • Tetrahydro-6a,7,8,9-trimethyl-6,6,9 pentyl-3 6H-

dibenzo[b,d] pyranne o1-1 • (6aR,10aR)-Hexahydro-6a,7,8,9,10,10a

dimethyl-6,6 methylene-9 pentyl-3 6Hdibenzo [b,d] pyranne o1-1

82 Para-fluorofentanyl 83 Parahexyl 84 PEPAP (phenethylphenyl-

acetoxypiperidine)

85 Phenadoxone 86 Phenampromide 87 Phenomorphane 88 Phenoperidine 89 Pholcodine 90 Piritramide 91 PMA (para-

methoxyamphetamine)

92 Poppy seeds 93 Poppy straw 94 Proheptazine 95 Properidine 96 Propiram 97 Psilocine, psilotsin 98 Psilocybine 99 Racemoramide 100 Rolicyclidine

22

Category 2–Strictly Controlled Plants and Substances with a Medical Use S/no Name S/no Name

1 Alfentanil 31 Methadone 2 Alphaprodine 32 Methadone intermediate 3 Amfetamine 33 Methylphenidate 4 Amobarbital 34 Metopon 5 Aniledirine 35 Moramide, intermediate 6 Bezitramide 36 Morphine 7 Coca (leaf) 37 Nicodicodine 8 Cocaine 38 Norcodeine 9 Codeine 39 N-oxymorphine 10 Codoxime 40 Opium 11 Delta-9-tetrahydro cannabinol and its variants 41 Oxycodone 12 Dexamfetamine 42 Oxymorphone 13 Dextropropoxyphene 43 Pethidine 14 Dihydrocodeine 44 Pethidine, intermediate A 15 Dihydromorphine 45 Pethidine, intermediate B 16 Diphenoxylate 46 Pethidine, intermediate C 17 Dronabinol 47 Phenazocine 18 Ecgonine, its esters and derivatives 48 Phencyclidine 19 Ethylmorphine 49 Phenmetrazine 20 Fentanyl 50 Piminodine 21 Glutethimide 51 Metamfetamine racemate 22 Hydrocodone 52 Racemethorphane 23 Hydromorphone 53 Racemorphane 24 Isomethadone 54 Remifentanil 25 Levamfetamine 55 Secobarbital 26 Levomethamphetamine 56 Sufentanil 27 Levomethorphane 57 Thebaine 28 Levorphanol 58 Zipeprol 29 Metamfetamine 30 Metazocine

23

Category 3–Controlled Plants and Substances with a Medical Use S/No Name S/No Name

1 Acetyldihydrocodeine 41 Lorazepam 2 Allobarbital 42 Lormetazepam 3 Alprazolam 43 Mazindol 4 Amfepramone 44 Medazepam 5 Barbital 45 Mefenorex 6 Benzfetamine 46 Meprobamate 7 Bromazepam 47 Mesocarbe 8 Brotizolam 48 Methylphenobarbital 9 Buprenorphine 49 Methyprylone 10 Butalbital 50 Midazolam 11 Butobarbital 51 Nicocodine 12 Camazepam 52 Nicodicodine 13 Cathine 53 Nimetazepam 14 Chlordiazepoxide 54 Nitrazepam 15 Clobazam 55 Norcodeine 16 Clonazepam 56 Nordazepam 17 Clorazepate 57 Oxazepam 18 Clotiazepam 58 Oxazolam 19 Cloxazolam 59 Pemoline 20 Codeine 60 Pentazocine 21 Cyclobarbital 61 Pentobarbital 22 Delorazepam 62 Phendimetrazine 23 Diazepam 63 Phenobarbital 24 Dihydrocodeine 64 Phentermine 25 Estazolam 65 Pholcodine 26 Ethchlorvynol 66 Pinazepam 27 Ethinamate 67 Pipradrol 28 Ethylmorphine 68 Prazepam 29 Fencamfamine 69 Pyrovalerone 30 Fenproporex 70 Secbutabarbital 31 Fludiazepam 71 Temazepam 32 Flunitrazepam 72 Tetrazepam 33 Flurazepam 73 Triazolam 34 GHB (gamma-hydroxybutyric acid) 74 Vinylbital 35 Halazepam 75 Zolpidem 36 Haloxazolam 37 Ketazolam 38 Lefetamine 39 Loflazepate ethyl 40 Loprazolam

24

Category 4–Substances Frequently Used in the Manufacture of Narcotic Drugs and Psychotropic Substances (Chemical Precursors) S/No Name

1 Acid N-acetylanthranilic 2 Acid lysergic 3 Anhydride acetic 4 Ephedrine 5 Ergometrine 6 Ergotamine 7 Isosafrole 8 Methylenedioxy-3,4 phenyl propanone-2 9 Norephedrine 10 Potassium permanganate 11 Phenyl-1 propanone-2 12 Piperonal 13 Pseudoephedrine 14 Safrole 15 Acetone 16 Acid anthranilic 17 Acid hydrochloric 18 Acid phenylacetic 19 Acid sulfuric 20 Methylethyl ketone 21 Piperidine 22 Toluene 23 Ethylether